Vivance
PrivateLast Round
Series B
Sep 13, 2023
Total Funding Raised
$60M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vivance operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series B round in September 2023.
Vivance is a healthcare technology company that develops ultraportable dialysis devices and digital solutions for chronic kidney disease management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivance Comparables
Compare Vivance with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Byonyks | 83% | |
| Diality | 81% | |
| Triomed AB | 79% |
For institutional investors. Book with your work email.
Vivance Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 13, 2023 | ||||
| Series A | Dec 12, 2019 | ||||
| VC Round | Dec 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vivance Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eckuity | Series B |
| SEEDS Capital | Series A |
| Lion X Fund | Series B |
| Vickers Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 734% MoM, reaching 1.2K.
- Sep 13, 2023
$20M round led by Lion X Fund and Vickers Venture Partners.
For institutional investors. Book with your work email.
Vivance Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivance's valuation, stock price, and market status.
Is Vivance a public or private company?
Vivance is a private company.
What is the current stock price of Vivance?
Vivance is a private company, so its shares have no public market price. Caplight tracks Vivance's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivance worth (valuation)?
Valuation information for Vivance is not publicly available.
Can I buy Vivance stock?
Vivance shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivance's last funding round?
Vivance's most recent funding round was Series B on September 13, 2023.
Who are the main investors in Vivance?
Key investors in Vivance include Lion X Fund, Vickers Venture Partners.
Will Vivance IPO soon?
No public IPO plans have been announced for Vivance.
How can I track Vivance secondary market activity?
Caplight tracks bids, offers, and trades in Vivance's shares on secondary markets.